Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Granules India bags USFDA nod for Esomeprazole Magnesium Delayed Release Capsules for GERD symptoms

Ruchika Sharma19 Oct 2023 11:31 AM IST

Hyderabad: Granules India Limited has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application...

Glenmark Pharma bags USFDA nod for generic version of Otezla Tablets

Ruchika Sharma18 Oct 2023 3:30 PM IST

Mumbai: Glenmark Pharmaceuticals Ltd. has announced that the Company has received final approval from the United States Food & Drug Administration...

USFDA Grants Orphan Drug Status to Shilpa-mAbTree Biologic for Rare Blood Cancers

Shilpa Medicare Jadcherla facility clears TGA, Australia GMP inspection

Ruchika Sharma18 Oct 2023 2:30 PM IST

Karnataka: Shilpa Medicare has recently informed through a BSE filing that the Company’s finished dosage form manufacturing facility, Unit IV,...

Mankind Pharma names Prateek Dubey as President- Global Chief Human Resource Officer

Ruchika Sharma18 Oct 2023 1:30 PM IST

Mumbai: Pharma major, Mankind Pharma, has announced the appointment of Prateek Dubey as President – Global Chief Human Resource Officer...

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility

Ruchika Sharma18 Oct 2023 12:30 PM IST

Bengaluru: Biocon Sdn Bhd., a step-down subsidiary of Biocon Biologics Limited has received a communication from the U.S. Food and Drug...

Piramal Pharma Solutions Grangemouth facility gets updated MHRA GMP certificates

Piramal Pharma Solutions unveils in-vitro biology capabilities at Ahmedabad Discovery Services Site

Ruchika Sharma18 Oct 2023 11:31 AM IST

Mumbai: Piramal Pharma Limited’s Pharma Solutions (PPS) business, a Contract Development and Manufacturing Organization (CDMO), has formally announced...

European Commission nod to Merck Keytruda for non-small cell lung cancer at high risk of recurrence

Ruchika Sharma17 Oct 2023 3:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca gets USFDA priority review for Tagrisso plus chemotherapy for EGFR-mutated advanced lung cancer

Ruchika Sharma17 Oct 2023 2:24 PM IST

Cambridge: AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and...

Hitesh Kumar Maheshwari joins Ipca Labs as President - RnD (Formulations)

Ruchika Sharma17 Oct 2023 1:30 PM IST

Mumbai: Ipca Labs has appointed Hitesh Kumar Maheshwari as President – R&D (Formulations) with effect from 16th October, 2023. "He will be...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck gets USFDA nod for neoadjuvant/ adjuvant Keytruda for resectable non-small cell lung cancer

Ruchika Sharma17 Oct 2023 12:54 PM IST

The approval marks the sixth NSCLC indication for KEYTRUDA.

OPPI names Anil Matai as Director General

Ruchika Sharma17 Oct 2023 11:49 AM IST

Anil has functioned on the boards of Zydus Healthcare, Bayer Zydus Pharma, Novartis Healthcare and Biochem Pharmaceutical Industries.

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

Sun Pharma announces positive Phase III results for Nidlegy in locally advanced fully resectable melanoma patients

Ruchika Sharma16 Oct 2023 2:49 PM IST

Nidlegy is also being developed in dedicated Phase II clinical trials for the treatment of aggressive forms of non-melanoma skin cancer, including...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok